{"id":120047,"date":"2023-09-20T09:48:03","date_gmt":"2023-09-20T09:48:03","guid":{"rendered":"https:\/\/learnexams.com\/blog\/?p=120047"},"modified":"2023-09-20T09:48:06","modified_gmt":"2023-09-20T09:48:06","slug":"midterm-exams-nr566-nr-566-advanced-pharmacology-care-of-the-family-exam-questions-and-verified-answersweeks-1-4-covered-all-updates-bundled-together-with-complete-solutions-chamberlain","status":"publish","type":"post","link":"https:\/\/www.learnexams.com\/blog\/2023\/09\/20\/midterm-exams-nr566-nr-566-advanced-pharmacology-care-of-the-family-exam-questions-and-verified-answersweeks-1-4-covered-all-updates-bundled-together-with-complete-solutions-chamberlain\/","title":{"rendered":"Midterm Exams: NR566\/ NR 566 Advanced Pharmacology Care of the Family Exam | Questions and Verified Answers|Weeks 1-4 Covered| ALL Updates BUNDLED TOGETHER WITH COMPLETE SOLUTIONS)- Chamberlain"},"content":{"rendered":"\n<p>NR 566 \/ NR566 Advanced Pharmacology<br>Care of the Family Midterm Exam |<br>Already graded A | Latest, 2020 \/ 2021|<br>Chamberlain College<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Mild intermittent asthma<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Symptoms occur less often than twice a week and the patient is asymptomatic<br>between exacerbations; nighttime symptoms occur less than twice a month; and peak<br>expiratory flow (PEF) is greater than 80% predicted. The use of short-acting beta2<br>agonists (SABA) should be less than twice a week, unless used for exercise-induced<br>bronchospasm (EIB).<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Mild persistent asthma<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Symptoms occur more often than twice a week but less often than once a day and<br>exacerbations may affect activity; nighttime symptoms occur 3 to 4 times a month;<br>and PEF is greater than 80% predicted. Patients with mild persistent asthma may use<br>their short-acting beta2 agonists more than twice a week but not daily, and not more<br>than once daily.<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Moderate persistent asthma<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The patient is having daily symptoms; requires daily use of a beta2 agonist;<br>exacerbations affect normal activity; nighttime symptoms occur more often than once<br>a week; and PEF is greater than 60% to less than 80%.<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Severe persistent asthma<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The patient has some degree of symptoms all the time; extremely limited physical<br>activity and frequent exacerbations; frequent nighttime symptoms, often 7 days a<br>week; and decreased lung function (PEF less than 60% predicted). Table 30-1<br>outlines the classifications of asthma severity in patients aged 12 years or older.<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Risk factors for fatal asthma attacks<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Previous severe exacerbations requiring intubation or ICU.<\/li>\n\n\n\n<li>Two or more hospitalizations.<\/li>\n\n\n\n<li>More than 3 ED visits in the past year.<\/li>\n\n\n\n<li>Use of more than 2 SABA canisters per month.<\/li>\n\n\n\n<li>Difficulty perceiving airway obstruction or worsening asthma.<\/li>\n\n\n\n<li>Low socioeconomic status or inner-city residence.<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Asthma step therapy<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The Expert Panel Report 3: Guidelines (NAEPP, 2007) recommends a stepwise<br>approach to the pharmacological management of asthma. Management can begin at a<\/li>\n<\/ul>\n\n\n\n<p>higher level and gradually step down or start low and move up, depending on the<br>patient&#8217;s status when beginning treatment.<br>o Step 1: SABA PRN<br>o Step 2: Low dose ICS<br>o Step 3: Medium dose ICS<br>o Step 4: Medium dose ICS + LABA or Montelukast<br>o Step 5: High dose ICS + LABA or Mentelukast<br>o Step 6: High dose ICS + LABA or Montelukast + oral corticosteroids<\/p>\n\n\n\n<ol class=\"wp-block-list\" start=\"7\">\n<li>COPD therapy and goals of treatment<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Slow the disease process<\/li>\n\n\n\n<li>Maintain quality of life<\/li>\n\n\n\n<li>Medications<\/li>\n\n\n\n<li>Quit smoking<\/li>\n\n\n\n<li>Nutrition<\/li>\n\n\n\n<li>Infection protection<\/li>\n\n\n\n<li>Exercise -pulmonary rehabilitation improve function and quality of life<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\" start=\"7\">\n<li>Respiratory drug interactions with digoxin<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Albuterol can lower digoxin levels in body<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\" start=\"7\">\n<li>Patient education for treatment of asthma<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Basic facts about asthma.<\/li>\n\n\n\n<li>Medication skills.<\/li>\n\n\n\n<li>Self-monitoring skills.<\/li>\n\n\n\n<li>Specific to drug therapy.<\/li>\n\n\n\n<li>Reasons for the drug.<\/li>\n\n\n\n<li>Drugs as part of the total treatment regimen.<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\" start=\"7\">\n<li>Use of oral corticosteroids in the treatment of COPD<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Corticosteroids have nonspecific anti-inflammatory activity at multiple points in the<br>inflammatory process. Because of the cellular-level airway changes that define<br>COPD, corticosteroids&#8217; effects are less dramatic in COPD than those seen in asthma.<br>Yet corticosteroids are key components in the management of stable COPD and<br>COPD exacerbations.<\/li>\n\n\n\n<li>The use of daily inhaled corticosteroids (ICS) in the COPD patient has mixed results<br>in clinical studies.<\/li>\n\n\n\n<li>inhaled corticosteroids do not modify the long-term decline in FEV1 seen in COPD,<br>but as both monotherapy and in combination with inhaled bronchodilators they<br>decrease exacerbations and improve health status in patients with symptomatic COPD<\/li>\n\n\n\n<li>Therefore, the current ACP and GOLD guidelines recommend starting a patient on<br>moderate- to high-dose inhaled corticosteroids<\/li>\n\n\n\n<li>Combination therapy of ICS and a long-acting beta agonist, such as Advair<br>(salmeterol\/fluticasone), is more effective in decreasing exacerbations than either<br>agent alone<\/li>\n<\/ul>\n\n\n\n<p>NR 566 \/ NR566 Advanced Pharmacology<br>Care of the Family Midterm Review Quiz<br>bank | LATEST, 2020\/2021 |Q &amp; A|<br>Chamberlain College<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Hypoglycemia can result from the action of either insulin or an oral hypoglycemic. Signs<br>and symptoms of hypoglycemia include:<br>A. \u201cFruity\u201d breath odor and rapid respiration<br>B. Diarrhea, abdominal pain, weight loss, and hypertension<br>C. Dizziness, confusion, diaphoresis, and tachycardia<br>D. Easy bruising, palpitations, cardiac dysrhythmias, and coma<\/li>\n\n\n\n<li>Nonselective beta blockers and alcohol create serious drug interactions with insulin<br>because they:<br>A. Increase blood glucose levels<br>B. Produce unexplained diaphoresis<br>C. Interfere with the ability of the body to metabolize glucose<br>D. Mask the signs and symptoms of altered glucose levels<\/li>\n\n\n\n<li>Lispro is an insulin analogue produced by recombinant DNA technology. Which of the<br>following statements about this form of insulin is NOT true?<br>A. Optimal time of preprandial injection is 15 minutes.<br>B. Duration of action is increased when the dose is increased.<br>C. It is compatible with neutral protamine Hagedorn insulin.<br>D. It has no pronounced peak.<\/li>\n\n\n\n<li>The decision may be made to switch from twice daily neutral protamine Hagedorn (NPH)<br>insulin to insulin glargine to improve glycemia control throughout the day. If this is done:<br>A. The initial dose of glargine is reduced by 20% to avoid hypoglycemia.<br>B. The initial dose of glargine is 2 to 10 units per day.<br>C. Patients who have been on high doses of NPH will need tests for insulin antibodies.<br>D. Obese patients may require more than 100 units per day.<\/li>\n\n\n\n<li>When blood glucose levels are difficult to control in type 2 diabetes some form of insulin<br>may be added to the treatment regimen to control blood glucose and limit complication<br>risks. Which of the following statements is accurate based on research?<\/li>\n<\/ol>\n\n\n\n<p>A. Premixed insulin analogues are better at lowering HbA1C and have less risk for<br>hypoglycemia.<br>B. Premixed insulin analogues and the newer premixed insulins are associated with more<br>weight gain than the oral antidiabetic agents.<br>C. Newer premixed insulins are better at lowering HbA1C and postprandial glucose<br>levels than long-acting insulins.<br>D. Patients who are not controlled on oral agents and have postprandial hyperglycemia can<br>have neutral protamine Hagedorn insulin added at bedtime.<\/p>\n\n\n\n<ol class=\"wp-block-list\" start=\"6\">\n<li>Metformin is a primary choice of drug to treat hyperglycemia in type 2 diabetes because<br>it:<br>A. Substitutes for insulin usually secreted by the pancreas<br>B. Decreases glycogenolysis by the liver<br>C. Increases the release of insulin from beta cells<br>D. Decreases peripheral glucose utilization<\/li>\n\n\n\n<li>Prior to prescribing metformin, the provider should:<br>A. Draw a serum creatinine to assess renal function<br>B. Try the patient on insulin<br>C. Tell the patient to increase iodine intake<br>D. Have the patient stop taking any sulfonylurea to avoid dangerous drug interactions<\/li>\n\n\n\n<li>The action of \u201cgliptins\u201d is different from other antidiabetic agents because they:<br>A. Have a low risk for hypoglycemia<br>B. Are not associated with weight gain<br>C. Close ATP-dependent potassium channels in the beta cell<br>D. Act on the incretin system to indirectly increase insulin production<\/li>\n\n\n\n<li>Sitagliptin has been approved for:<br>A. Monotherapy in once-daily doses<br>B. Combination therapy with metformin<br>C. Both 1 and 2<br>D. Neither 1 nor 2<\/li>\n\n\n\n<li>GLP-1 agonists:<br>A. Directly bind to a receptor in the pancreatic beta cell<br>B. Have been approved for monotherapy<br>C. Speed gastric emptying to decrease appetite<br>D. Can be given orally once daily<\/li>\n\n\n\n<li>Avoid concurrent administration of exenatide with which of the following drugs?<br>A. Digoxin<br>B. Warfarin<\/li>\n<\/ol>\n\n\n\n<p>C. Lovastatin<br>D. All of the above<\/p>\n\n\n\n<ol class=\"wp-block-list\" start=\"12\">\n<li>Administration of exenatide is by subcutaneous injection:<br>A. 30 minutes prior to the morning meal<br>B. 60 minutes prior to the morning and evening meal<br>C. 15 minutes after the evening meal<br>D. 60 minutes before each meal daily<\/li>\n\n\n\n<li>Potentially fatal granulocytopenia has been associated with treatment of hyperthyroidism<br>with propylthiouracil. Patients should be taught to report:<br>A. Tinnitus and decreased salivation<br>B. Fever and sore throat<br>C. Hypocalcemia and osteoporosis<br>D. Laryngeal edema and difficulty swallowing<\/li>\n\n\n\n<li>Elderly patients who are started on levothyroxine for thyroid replacement should be<br>monitored for:<br>A. Excessive sedation<br>B. Tachycardia and angina<br>C. Weight gain<br>D. Cold intolerance<\/li>\n\n\n\n<li>Which of the following is not an indication that growth hormone supplements should be<br>discontinued?<br>A. Imaging indication of epiphyseal closure<br>B. Growth curve increases have plateaued<br>C. Complaints of mild bone pain<br>D. Achievement of anticipated height goals<\/li>\n\n\n\n<li>Besides osteoporosis, IV bisphosphonates are also indicated for:<br>A. Paget\u2019s Disease<br>B. Early osteopenia<br>C. Renal cancer<br>D. Early closure of cranial sutures<\/li>\n\n\n\n<li>What is the role of calcium supplements when patients take bisphosphonates?<br>A. They must be restricted to allow the medication to work.<br>B. They must be taken in sufficient amounts to provide foundational elements for bone<br>growth.<br>C. They must be taken at the same time as the bisphosphonates.<br>D. They only work with bisphosphonates if daily intake is restricted.<\/li>\n<\/ol>\n\n\n\n<p>NR 566 \/ NR566 Advanced Pharmacology Care of the Family<br>Midterm Exam Review<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>TB screening test? Next step if +?<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>PPD<\/li>\n\n\n\n<li>&gt;15mm, &gt;10mm if prison, healthcare, nursing home, DM, ETOH, chronically<br>ill, &gt;5mm for AIDS, immune suppressed<\/li>\n\n\n\n<li>If + PPD &#8211;&gt; do CXR.<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>For treatment of existing osteoporosis, the dose of alendronate<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>10 mg\/day or 70 mg\/week<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Initial dosage for bone less prevention alendronate and risedronate<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>5 mg\/day or 35 mg\/week<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>For treatment of existing osteoporosis, the dose of risedronate<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>75 mg for 2 consecutive days or 150 mg once a month<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Alendronate (Fosamax)<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Therapy with 10 mg daily can increase bone density by up to 10% after 3<br>years and can decrease vertebral and hip fractures by 50%<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Testosterone replacement therapy<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>risk of prostate cancer<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Testosterone replacement therapy<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Erythrocytosis is a risk; Hgb and Hct levels checked, expect increase first 6<br>mths, unless Hgb level higher than 17.5 g\/dL, Hct higher than 54%, or both<br>suggests overtreatment or occasionally abuse. IM happens more than<br>transdermal. If the Hct is greater than 54%, therapy is stopped until the Hct<br>decreases to a safe level. The patient should also be evaluated for hypoxia<br>and sleep apnea. Restarting therapy at a reduced dose usually solves<br>problems.<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Adults with vitamin B12 deficiency that is not pernicious anemia<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>1,000 mcg of oral cobalamin are given until normal B12 levels are achieved\u2014<br>usually 6 to 12 weeks. In seriously ill patients, both vitamin B12 and folic<br>acid may need to be administered.<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Who cannot get TRT<\/li>\n<\/ol>\n\n\n\n<p>NR 566 \/ NR566 Advanced Pharmacology Care of the Family<br>Final Exam Review<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Chlamydia first line treatment<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>doxycycline 100 mg orally twice daily for 7 day<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Uncomplicated gonococcal first line treatment<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>weight &lt;150kg- single IM dose ceftriaxone 500mg<\/li>\n\n\n\n<li>weight &gt;150kg- single IM dose ceftriaxone 1g<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>bacterial vaginosis treatment<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>metronidazole 500 mg orally twice daily for 7 days<\/li>\n\n\n\n<li>metronidazole 0.75% gel, 5 grams intravaginally once a day for 5 days<\/li>\n\n\n\n<li>or clindamycin 2% cream, 5 grams intravaginally at bedtime for 7 days<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>women treatment of trichomoniasis<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>metronidazole 500 mg twice daily for 7 days<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>men treatment of trichomoniasis<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>single dose of 2 grams of oral metronidazole<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Syphilis treatment<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>benzathine penicillin G given as 2.4 million units once as a single<br>intramuscular dose<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>HSV Treatment for first episode<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>oral Acyclovir 400mg tid x7-10 days<\/li>\n\n\n\n<li>or oral valacyclovir bid x7-10 days<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>HSV treatment for recurrent episodes<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Acyclovir 800 mg BID x 5 days<\/li>\n\n\n\n<li>-Famciclovir 1 gram BID x 1 day<\/li>\n\n\n\n<li>-Valacyclovir 1 grams once daily x 5 day<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>A 17-year-old male has a presumptive diagnosis of gonococcal urethritis based on a<br>Gram&#8217;s stain of a urethral discharge specimen that shows multiple gram-negative<br>intracellular diplococci. Nucleic acid amplification testing (NAAT) for Neisseria<br>gonorrhoeae and Chlamydia trachomatis are sent. He denies any history of drug allergies.<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ceftriaxone 500 mg intramuscularly in a single dose plus oral doxycycline<br>100 mg twice daily for 7 days<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Osteoporosis<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>lone bone mass and increased bone fragility<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>most common disorder of calcium metabolism<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>osteoporosis<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>how does hormone therapy decrease osteoporosis<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>it reduces postmenopausal bone loss<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>What warning comes on hormone therapy<\/li>\n<\/ol>\n\n\n\n<p>Midterm Exam: NR566\/ NR 566 (New<br>2023\/ 2024 Update) Advanced<br>Pharmacology Care of the Family Exam<br>Review| Questions and Verified Answers &#8211;<br>Chamberlain<br>Q Organic sunscreen needs what ingredient to be effective<br>\u2713 Answer: Avobenzone<br>Q 1st line for mild to moderate acne<br>\u2713 Answer: Topical antibiotics\/retinoids- Benzoyl peroxide<br>Q 1st line for severe acne<br>\u2713 Answer: Oral therapy- Isotretinoin<br>Q Which treatment would be selected over another for acne?<br>\u2713 Answer: Treatment depends on severity of acne.<\/p>\n\n\n\n<p>Q Salicylic acid education<br>\u2713 Answer: Salicylate toxicity is not a concern when applied only to the face;<br>however, if acne is extensive and the drug is applied to the trunk, back, and other<br>locations, salicylate toxicity may occur. Monitoring for signs and symptoms of<br>salicylism (e.g., hyperpnea, tinnitus, nausea and vomiting, and mental status<br>changes) is indicated. Peeling and drying are adverse effects, not desired effects,<br>of salicylic acid. Tinnitus is a symptom of systemic toxicity that requires<br>immediate attention.<br>Q Isotretinoin patient education<br>\u2713 Answer: Avoid driving, protect from sun, frequent blood tests, discontinue<br>tetracycline, alcohol should be avoided, contraindicated in pregnancy-defects in<br>developing fetus, cannot donate blood, avoid supplements containing vitamin A,<br>avoid waxing and laser therapy, notify of depression.<br>Q When to prescribe an intranasal glucocorticoid<br>\u2713 Answer: Prevention and treatment of seasonal and perineal rhinitis.<br>Q Moderate to severe symptoms treatment<br>\u2713 Answer: \u00b7 Combination therapy<br>~ Intranasal glucocorticoids<\/p>\n\n\n\n<p>Q Select the treatment agent that corresponds to the symptom(s). Intermittent sneezing,<br>nasal itching, and rhinorrhea<br>\u2713 Answer: \u00b7 Intranasal antihistamine<br>~ Oral antihistamine<br>Q Select the treatment agent that corresponds to the symptom(s).<br>Nasal congestion is dominant complaint<br>\u2713 Answer: \u00b7 Oral decongestant<br>Q Select the treatment agent that corresponds to the symptom(s).<br>Mild symptoms<br>\u2713 Answer: \u00b7 Oral antihistamine<br>Q Which of the following symptoms of CNS stimulation occur with the use of oral<br>sympathomimetics? Select all that apply.<br>\u2713 Answer: \u00b7 restlessness<br>~ anxiety<br>~ insomnia<br>~ irritability<\/p>\n\n\n\n<p>Midterm Exam: NR566\/ NR 566 Advanced<br>Pharmacology Care of the Family Exam |<br>Questions and Verified Answers (2023\/<br>2024 New Update)- Chamberlain<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Budesonide risks of use in children<br>\u2713 Answer: risk for delayed growth<\/li>\n\n\n\n<li>Ketoconazole and omeprazole concurrently- what does the patient need to know<br>\u2713 Answer: decrease absorption of ketoconazole and reduce effectiveness<\/li>\n\n\n\n<li>Which weight loss drug(s) are associated with a suicide risk in children, adolescents, and<br>young adults?<br>\u2713 Answer: Naltrexone and bupropion (contrave)<\/li>\n\n\n\n<li>Which weight loss drugs are DEA scheduled drugs?<br>\u2713 Answer: Diethylpropion<br>\u2713 Locaserin<br>\u2713 Phentermine\/topiramate (Phentermine is scheduled, not topiramate)<br>\u2713 Phendimetrazine<\/li>\n\n\n\n<li>At what BMI level should bariatric surgery be considered?<br>\u2713 Answer: BMI 35 or more<\/li>\n\n\n\n<li>Topiramate -Therapeutic effect<br>\u2713 Answer: induces sense of satiety (Sense of satisfaction- don&#8217;t feel hungry)<\/li>\n\n\n\n<li>How to discontinue phentermine and\/or topiramate<br>\u2713 Answer: if the person has not lost 5% of weight loss by 6 months then d\/c<br>medication<br>\u2713 tolerance can develop n 6-12 weeks<\/li>\n\n\n\n<li>Which of the following would be contraindicated to prescribing phentermine\/topiramate?<br>\u2713 Answer: glaucoma, hyperthyroidism, hypertension<\/li>\n\n\n\n<li>Orlistat patient education (orlistat acts in the GI tract to reduce absorption of fat)<br>\u2713 Answer: may cause hypothyroidism in patients taking levothyroxine (two drugs<br>should be administered 4 hours apart)<br>\u2713 take vitamins A, D, E, and K<br>\u2713 stools often fatty or oily and fecal incontinence can occur (bulk forming laxative)<br>\u2713 taken with food<br>\u2713 vitamin k deficency can occur and compound effects of warfarin, so coagulation<br>must be monitored<br>\u2713 taking more of the meds in a day won&#8217;t help weight loss<br>\u2713 not for patients with malabsorption issues or cholestasis<\/li>\n\n\n\n<li>Liraglutide- Baseline data needed<br>\u2713 Answer: Ha1C, lipids, renal function<\/li>\n\n\n\n<li>Ongoing monitoring\/assessment needs &#8211; Liraglutide<br>\u2713 Answer: assess for s\/s of cholecystitis, pancreatitis, depression, and suicidal<br>thoughts<br>\u2713 do not give to someone with thyroid cancer or history of thyroid cancer<\/li>\n\n\n\n<li>Loarcaserin- Baseline data needed<br>\u2713 Answer: baseline assessment to rule out valvular disorders and pulmonary<br>hypertension<\/li>\n\n\n\n<li>Ongoing monitoring\/assessment needs &#8211; Loarcaserin<br>\u2713 Answer: CBC w\/ differential for s\/s of blood dyscrasias<\/li>\n\n\n\n<li>Naltrexone\/bupropion (contrave)- Baseline data needed<br>\u2713 Answer: blood glucose, liver function, renal functions, and mental status<\/li>\n\n\n\n<li>Ongoing monitoring\/assessment needs &#8211; Contrave (Naltrexone\/bupropion)<br>\u2713 Answer: periodic assessments for blood glucose, liver and renal function, s\/s of<br>depression, anxiety, panic attacks, or suicidal ideation, and mania<br>\u2713 think naltrexone (opioid antagonist) so pain medicine will not work for them<\/li>\n\n\n\n<li>Phentermine baseline data needed<br>\u2713 Answer: cardiac assessment<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>NR 566 \/ NR566 Advanced PharmacologyCare of the Family Midterm Exam |Already graded A | Latest, 2020 \/ 2021|Chamberlain College higher level and gradually step down or start low and move up, depending on thepatient&#8217;s status when beginning treatment.o Step 1: SABA PRNo Step 2: Low dose ICSo Step 3: Medium dose ICSo Step 4: [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[25],"tags":[],"class_list":["post-120047","post","type-post","status-publish","format-standard","hentry","category-exams-certification"],"_links":{"self":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts\/120047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/comments?post=120047"}],"version-history":[{"count":0,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts\/120047\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/media?parent=120047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/categories?post=120047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/tags?post=120047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}